Skip to content

Drug interactions

Gemtuzumab + Memantine-donepezil

Severity: Moderate

Gemtuzumab and Memantine-donepezil: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Donepezil and gemtuzumab ozogamicin have each been linked to QT prolongation. Together they may increase the likelihood of arrhythmia, particularly in oncology patients who often have electrolyte disturbances or other QT-prolonging drugs.

What this interaction means in plain words

Gemtuzumab and Memantine-donepezil can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Additive QT prolongation; gemtuzumab's effect is thought to be related to its calicheamicin payload.

What to do

Check ECG and electrolytes before and during treatment. Correct potassium and magnesium and review other QT-prolonging drugs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Gemtuzumab and Memantine-donepezil, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Gemtuzumab with Memantine-donepezil?

MediHelp rates the interaction as moderate. Gemtuzumab and Memantine-donepezil can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Donepezil and gemtuzumab ozogamicin have each been linked to QT prolongation. Together they may increase the likelihood of arrhythmia, particularly in oncology patients who often have electrolyte disturbances or other QT-prolonging drugs.

How serious is the interaction between Gemtuzumab and Memantine-donepezil?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check ECG and electrolytes before and during treatment. Correct potassium and magnesium and review other QT-prolonging drugs.

What other medicines interact with Memantine-donepezil?

MediHelp also lists interactions of Memantine-donepezil with, for example, Dronedarone, Thioridazine, Amantadine. The full list is on the Memantine-donepezil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in